Season 14 · Episode 17
S14 Ep17: Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC
OncLive® On Air · OncLive® On Air
September 16, 202518m 28s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast, experts Aditya Bardia, MD, MPH, FASCO, Erika P. Hamilton, MD, and Virginia Kaklamani, MD, DSc, discuss frequently asked questions regarding the use of antibody-drug conjugates (ADCs) in triple-negative breast cancer (TNBC).